Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer’s disease continuum
-
Published:2024-09-03
Issue:1
Volume:148
Page:
-
ISSN:1432-0533
-
Container-title:Acta Neuropathologica
-
language:en
-
Short-container-title:Acta Neuropathol
Author:
Denning Amanda E.ORCID, Ittyerah Ranjit, Levorse Lisa M., Sadeghpour Niyousha, Athalye Chinmayee, Chung Eunice, Ravikumar Sadhana, Dong Mengjin, Duong Michael Tran, Li Yue, Ilesanmi Ademola, Sreepada Lasya P., Sabatini Philip, Lowe MaKayla, Bahena Alejandra, Zablah Jamila, Spencer Barbara E., Watanabe Ryohei, Kim Boram, Sørensen Maja Højvang, Khandelwal Pulkit, Brown Christopher, Hrybouski Stanislau, Xie Sharon X., de Flores Robin, Robinson John L., Schuck Theresa, Ohm Daniel T., Arezoumandan Sanaz, Porta Sílvia, Detre John A., Insausti Ricardo, Wisse Laura E. M., Das Sandhitsu R., Irwin David J., Lee Edward B., Wolk David A., Yushkevich Paul A.
Abstract
AbstractThe medial temporal lobe (MTL) is a hotspot for neuropathology, and measurements of MTL atrophy are often used as a biomarker for cognitive decline associated with neurodegenerative disease. Due to the aggregation of multiple proteinopathies in this region, the specific relationship of MTL atrophy to distinct neuropathologies is not well understood. Here, we develop two quantitative algorithms using deep learning to measure phosphorylated tau (p-tau) and TDP-43 (pTDP-43) pathology, which are both known to accumulate in the MTL and are associated with MTL neurodegeneration. We focus on these pathologies in the context of Alzheimer’s disease (AD) and limbic predominant age-related TDP-43 encephalopathy (LATE) and apply our deep learning algorithms to distinct histology sections, on which MTL subregions were digitally annotated. We demonstrate that both quantitative pathology measures show high agreement with expert visual ratings of pathology and discriminate well between pathology stages. In 140 cases with antemortem MR imaging, we compare the association of semi-quantitative and quantitative postmortem measures of these pathologies in the hippocampus with in vivo structural measures of the MTL and its subregions. We find widespread associations of p-tau pathology with MTL subregional structural measures, whereas pTDP-43 pathology had more limited associations with the hippocampus and entorhinal cortex. Quantitative measurements of p-tau pathology resulted in a significantly better model of antemortem structural measures than semi-quantitative ratings and showed strong associations with cortical thickness and volume. By providing a more granular measure of pathology, the quantitative p-tau measures also showed a significant negative association with structure in a severe AD subgroup where semi-quantitative ratings displayed a ceiling effect. Our findings demonstrate the advantages of using quantitative neuropathology to understand the relationship of pathology to structure, particularly for p-tau, and motivate the use of quantitative pathology measurements in future studies.
Funder
National Institute on Aging Lunds Universitet National Institute of Neurological Disorders and Stroke Alzheimer's Association
Publisher
Springer Science and Business Media LLC
Reference105 articles.
1. Barnes J, Ridgway GR, Bartlett J, Henley SMD, Lehmann M, Hobbs N et al (2010) Head size, age and gender adjustment in MRI studies: a necessary nuisance? NeuroImage 53:1244–1255. https://doi.org/10.1016/j.neuroimage.2010.06.025 2. Bejanin A, Murray ME, Martin P, Botha H, Tosakulwong N, Schwarz CG et al (2019) Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration. Brain J Neurol 142:3621–3635. https://doi.org/10.1093/brain/awz277 3. Berron D, Vogel JW, Insel PS, Pereira JB, Xie L, Wisse LEM et al (2021) Early stages of tau pathology and its associations with functional connectivity, atrophy and memory. Brain 144:2771–2783. https://doi.org/10.1093/brain/awab114 4. Botha H, Mantyh WG, Murray ME, Knopman DS, Przybelski SA, Wiste HJ et al (2018) FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis. Brain 141:1201–1217. https://doi.org/10.1093/brain/awy049 5. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239–259. https://doi.org/10.1007/BF00308809
|
|